The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...

Despite substantial health benefits, two GLP-1 receptor agonists weren't cost-effective at their current prices, according to ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

One effective action involves addressing obesity, a major driver of chronic disease and health care costs. Obesity is an ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

The Canadian Medical Association and the World Health Organization (WHO) consider obesity as a progressive chronic disease ...

A coalition of industry organizations is pressing employers to offer coverage for obesity as they would for other chronic ...

India must note that obesity is a public health challenge, waiting for holistic, multipronged and comprehensive interventions ...

Obesity is a chronic, progressive disease that affects one-third of adults in Florida. We cannot afford to continue ignoring ...